Avalon Investment & Advisory’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$10.8M Sell
143,093
-4,449
-3% -$336K 0.3% 102
2022
Q4
$11.3M Buy
+147,542
New +$11.2M 0.32% 96

Other funds holding CAH

Avalon Investment & Advisory's CAH Position: Q1 2023 in Review

Avalon Investment & Advisory reduced its Cardinal Health (CAH) stake by 3% in Q1 2023, selling an estimated $336K and leaving 143,093 shares worth $10.8M. The position accounts for 0.3% of the portfolio, ranked #102.

Avalon Investment & Advisory first reported a position in CAH in Q4 2022 and has held it in 2 quarters since. The position peaked at $11.3M in Q4 2022. 907 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

  • Avalon Investment & Advisory held 143,093 shares of Cardinal Health worth $10.8M as of Q1 2023.
  • Avalon Investment & Advisory sold 4,449 Cardinal Health shares in Q1 2023, an estimated $336K.
  • Cardinal Health made up 0.3% of Avalon Investment & Advisory's portfolio in Q1 2023, its #102 holding.
  • Avalon Investment & Advisory first reported a position in Cardinal Health in Q4 2022 and has held it in 2 quarters since.
  • Avalon Investment & Advisory's Cardinal Health position peaked at $11.3M in Q4 2022.
  • 907 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.